Malaysia’s TransLab Visits Ebiogen Headquarters to Discuss Distribution and OEM Collaboration
2025-12-15
본문
Ebiogen Inc. held a business meeting in Seoul on December 12, 2025, following a visit to its headquarters by representatives from Malaysia-based TransLab. During the meeting, the two companies engaged in detailed discussions focused on potential collaboration in product distribution and OEM manufacturing for Ebiogen’s key product lines.
Founded in 1984, TransLab is a leading company in Malaysia that has supplied a wide range of products in the medical, diagnostics, and research sectors for many years. With a strong local network and a trusted reputation in the market, TransLab’s visit served as an important opportunity for both parties to explore a cooperative framework that could support broader expansion of Ebiogen’s products across Malaysia and neighboring markets.
Beyond short-term supply discussions, both companies exchanged views on a mid- to long-term partnership strategy, taking into account market demand and potential portfolio expansion. The two parties also agreed to maintain close communication and to develop their collaboration step by step, including discussions on supply methods and potential joint business models.
Ebiogen will continue to expand strategic partnerships with global collaborators to ensure that a wide range of BAROSGEN-based products can be supplied and utilized reliably in international markets.
